367 related articles for article (PubMed ID: 25303610)
21. Circulating MicroRNAs, the Next-Generation Serum Biomarkers in Testicular Germ Cell Tumours: A Systematic Review.
Leão R; Albersen M; Looijenga LHJ; Tandstad T; Kollmannsberger C; Murray MJ; Culine S; Coleman N; Belge G; Hamilton RJ; Dieckmann KP
Eur Urol; 2021 Oct; 80(4):456-466. PubMed ID: 34175151
[TBL] [Abstract][Full Text] [Related]
22. MicroRNAs: Turning the Tide in Testicular Cancer.
Singla N; Lafin JT; Bagrodia A
Eur Urol; 2019 Nov; 76(5):541-542. PubMed ID: 31230742
[TBL] [Abstract][Full Text] [Related]
23. High Expression of microRNA-371a-3p in Cystic Fluid of Post-Chemotherapy Teratoma with Concurrent Normal Serum Levels in Patients with Non-Seminomatous Testicular Germ Cell Tumours.
Dieckmann KP; Hennig F; Anheuser P; Gehrckens R; Viehweger F; Wülfing C; Belge G
Urol Int; 2021; 105(1-2):21-26. PubMed ID: 33049748
[TBL] [Abstract][Full Text] [Related]
24. Differences in DNA methylation profiles by histologic subtype of paediatric germ cell tumours: a report from the Children's Oncology Group.
Williams LA; Mills L; Hooten AJ; Langer E; Roesler M; Frazier AL; Krailo M; Nelson HH; Bestrashniy J; Amatruda JF; Poynter JN
Br J Cancer; 2018 Oct; 119(7):864-872. PubMed ID: 30287918
[TBL] [Abstract][Full Text] [Related]
25. Malignant ovarian and testicular germ cell tumors: Common characteristics but different prognoses.
Sköld C; Jansson AK; Glimelius I
J Intern Med; 2024 Jun; 295(6):715-734. PubMed ID: 38468475
[TBL] [Abstract][Full Text] [Related]
26. Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study.
Dieckmann KP; Radtke A; Geczi L; Matthies C; Anheuser P; Eckardt U; Sommer J; Zengerling F; Trenti E; Pichler R; Belz H; Zastrow S; Winter A; Melchior S; Hammel J; Kranz J; Bolten M; Krege S; Haben B; Loidl W; Ruf CG; Heinzelbecker J; Heidenreich A; Cremers JF; Oing C; Hermanns T; Fankhauser CD; Gillessen S; Reichegger H; Cathomas R; Pichler M; Hentrich M; Eredics K; Lorch A; Wülfing C; Peine S; Wosniok W; Bokemeyer C; Belge G
J Clin Oncol; 2019 Jun; 37(16):1412-1423. PubMed ID: 30875280
[TBL] [Abstract][Full Text] [Related]
27. Serum Level of microRNA-375-3p Is Not a Reliable Biomarker of Teratoma.
Belge G; Grobelny F; Matthies C; Radtke A; Dieckmann KP
In Vivo; 2020; 34(1):163-168. PubMed ID: 31882475
[TBL] [Abstract][Full Text] [Related]
28. MicroRNAs miR-371-3 in serum as diagnostic tools in the management of testicular germ cell tumours.
Dieckmann KP; Spiekermann M; Balks T; Flor I; Löning T; Bullerdiek J; Belge G
Br J Cancer; 2012 Nov; 107(10):1754-60. PubMed ID: 23059743
[TBL] [Abstract][Full Text] [Related]
29. The metastatic potential of seminomatous germ cell tumours is associated with a specific microRNA pattern.
Ernst S; Heinzelmann J; Bohle RM; Weber G; Stöckle M; Junker K; Heinzelbecker J
Andrology; 2020 Nov; 8(6):1687-1698. PubMed ID: 32530514
[TBL] [Abstract][Full Text] [Related]
30. Germ cell tumors in children and adolescents in Finland: trends over 1969-2008.
Pauniaho SL; Salonen J; Helminen M; Heikinheimo O; Vettenranta K; Heikinheimo M
Cancer Causes Control; 2014 Oct; 25(10):1337-41. PubMed ID: 25060481
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA profiling of ovarian granulosa cell tumours reveals novel diagnostic and prognostic markers.
Cheng WT; Rosario R; Muthukaruppan A; Wilson MK; Payne K; Fong PC; Shelling AN; Blenkiron C
Clin Epigenetics; 2017; 9():72. PubMed ID: 28736583
[TBL] [Abstract][Full Text] [Related]
32. Identification of known and novel germ cell cancer-specific (embryonic) miRs in serum by high-throughput profiling.
Rijlaarsdam MA; van Agthoven T; Gillis AJ; Patel S; Hayashibara K; Lee KY; Looijenga LH
Andrology; 2015 Jan; 3(1):85-91. PubMed ID: 25382245
[TBL] [Abstract][Full Text] [Related]
33. Pediatric malignant germ cell tumors show characteristic transcriptome profiles.
Palmer RD; Barbosa-Morais NL; Gooding EL; Muralidhar B; Thornton CM; Pett MR; Roberts I; Schneider DT; Thorne N; Tavaré S; Nicholson JC; Coleman N;
Cancer Res; 2008 Jun; 68(11):4239-47. PubMed ID: 18519683
[TBL] [Abstract][Full Text] [Related]
34. NANOG controls testicular germ cell tumour stemness through regulation of MIR9-2.
Cardenas RP; Zyoud A; McIntyre A; Alberio R; Mongan NP; Allegrucci C
Stem Cell Res Ther; 2024 May; 15(1):128. PubMed ID: 38693576
[TBL] [Abstract][Full Text] [Related]
35. Circulating MicroRNAs for Detection of Germ Cell Tumours: A Narrative Review.
Fankhauser CD; Nuño MM; Murray MJ; Frazier L; Bagrodia A
Eur Urol Focus; 2022 May; 8(3):660-662. PubMed ID: 35537936
[TBL] [Abstract][Full Text] [Related]
36. Pre-Implementation Assessment of the Acceptability of Using Circulating microRNAs for Follow-Up of Malignant Germ-Cell Tumors.
Fern LA; Greenwood M; Smith S; Brand S; Coleman N; Stark DP; Murray MJ
Clin Genitourin Cancer; 2021 Oct; 19(5):381-387. PubMed ID: 33846102
[TBL] [Abstract][Full Text] [Related]
37. Expression pattern of clinically relevant markers in paediatric germ cell- and sex-cord stromal tumours is similar to adult testicular tumours.
Mosbech CH; Svingen T; Nielsen JE; Toft BG; Rechnitzer C; Petersen BL; Rajpert-De Meyts E; Hoei-Hansen CE
Virchows Arch; 2014 Nov; 465(5):567-77. PubMed ID: 25074678
[TBL] [Abstract][Full Text] [Related]
38. A novel C19MC amplified cell line links Lin28/let-7 to mTOR signaling in embryonal tumor with multilayered rosettes.
Spence T; Perotti C; Sin-Chan P; Picard D; Wu W; Singh A; Anderson C; Blough MD; Cairncross JG; Lafay-Cousin L; Strother D; Hawkins C; Narendran A; Huang A; Chan JA
Neuro Oncol; 2014 Jan; 16(1):62-71. PubMed ID: 24311633
[TBL] [Abstract][Full Text] [Related]
39. Molecular genetic evidence supporting diverse histogenic origins of germ cell tumors.
Jung SH; Park HC; Choi YJ; Song SY; Chung YJ; Lee SH
J Pathol; 2022 Jan; 256(1):38-49. PubMed ID: 34561860
[TBL] [Abstract][Full Text] [Related]
40. Associations between birth defects and childhood and adolescent germ cell tumors according to sex, histologic subtype, and site.
Schraw JM; Sok P; Desrosiers TA; Janitz AE; Langlois PH; Canfield MA; Frazier AL; Plon SE; Lupo PJ; Poynter JN
Cancer; 2023 Oct; 129(20):3300-3308. PubMed ID: 37366624
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
